Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Clinical Trials

National Cancer Institute "Cancer Moonshot Biobank"

CEMI-LUNG

Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes

A Retrospective Real-World Study Based on RATIONALE-307

NIS durvalumab

Clinical Outcomes and Quality Of Life After Minimally Invasive Segmentectomy Versus Lobectomy for Lung Cancer.

MK-3475-U01

ORI-EGI-03

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Experiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based Study

LBM-T790M

CB(NPC)²

LEPIDOPTERA

PRO-ACTIVE

ELEPHAS-04

Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

Harvesting Cells for Experimental Cancer Treatments

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.

A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled

UNCOVER

PET-CT Predicting Lymph Nodes Metastasis

Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)

PET-Rad-NSCLC

OSIREAL

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

SPARROW

Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations

3D Virtual Resection for Predicting Lung Function in VATS

Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy

Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

Brilliant

CHOICE

BASECAMP-1

PHILUCA

NAUTIC

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

PLANET

SORT

ALCG-01

Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.

OligoLung

Insomnia in Patients With Metastatic Lung Cancer

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery